Alpha DNA Investment Management’s Ambarella AMBA Stock Holding History

Alpha DNA Investment Management’s Portfolio AMBA Stock Details AMBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,466	Closed	-$470K	–	19
2024 Q4	$470K	Sell	6,466 -2,014	-24%	-$128K	0.18%	119
2024 Q3	$478K	Buy	8,480 +1,175	+16%	+$62.5K	0.18%	122
2024 Q2	$394K	Sell	7,305 -2,743	-27%	-$136K	0.15%	170
2024 Q1	$510K	Buy	10,048 +1,866	+23%	+$102K	0.19%	146
2023 Q4	$501K	Buy	+8,182	New	+$447K	0.2%	124
2022 Q1	–	Sell	-7,556	Closed	-$1.53M	–	117
2021 Q4	$1.53M	Sell	7,556 -1,301	-15%	-$241K	0.97%	63
2021 Q3	$1.38M	Sell	8,857 -4,639	-34%	-$533K	0.94%	71
2021 Q2	$1.44M	Buy	13,496 +7,254	+116%	+$718K	0.98%	55
2021 Q1	$626K	Sell	6,242 -2,320	-27%	-$253K	0.72%	67
2020 Q4	$786K	Buy	+8,562	New	+$600K	0.84%	42

Other funds holding AMBA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kodai Capital Management Chicago, Illinois $2.53B AUM 13.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpha DNA Investment Management's AMBA Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Ambarella (AMBA) in Q1 2025, closing a stake of 6,466 shares — an estimated $470K sold.

Alpha DNA Investment Management first reported a position in AMBA in Q4 2020 and held it in 10 quarters. The position peaked at $1.53M in Q4 2021. 297 funds tracked by Wall St. Rank hold AMBA as of Q1 2025.

Alpha DNA Investment Management reported no remaining Ambarella position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 6,466 Ambarella shares in Q1 2025, an estimated $470K.
Alpha DNA Investment Management first reported a position in Ambarella in Q4 2020 and held it in 10 quarters.
Alpha DNA Investment Management's Ambarella position peaked at $1.53M in Q4 2021.
297 funds tracked by Wall St. Rank held Ambarella as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.